Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 2
2008 2
2009 1
2010 3
2011 3
2012 5
2013 4
2014 2
2015 1
2017 3
2018 2
2019 1
2020 1
2021 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
The role of allergen-specific IgE, IgG and IgA in allergic disease.
Shamji MH, Valenta R, Jardetzky T, Verhasselt V, Durham SR, Würtzen PA, van Neerven RJJ. Shamji MH, et al. Allergy. 2021 Dec;76(12):3627-3641. doi: 10.1111/all.14908. Epub 2021 Jun 8. Allergy. 2021. PMID: 33999439 Free PMC article. Review.
Differential induction of allergen-specific IgA responses following timothy grass subcutaneous and sublingual immunotherapy.
Shamji MH, Larson D, Eifan A, Scadding GW, Qin T, Lawson K, Sever ML, Macfarlane E, Layhadi JA, Würtzen PA, Parkin RV, Sanda S, Harris KM, Nepom GT, Togias A, Durham SR. Shamji MH, et al. J Allergy Clin Immunol. 2021 Oct;148(4):1061-1071.e11. doi: 10.1016/j.jaci.2021.03.030. Epub 2021 Apr 2. J Allergy Clin Immunol. 2021. PMID: 33819508 Free article. Clinical Trial.
Nasal allergen-neutralizing IgG4 antibodies block IgE-mediated responses: Novel biomarker of subcutaneous grass pollen immunotherapy.
Shamji MH, Kappen J, Abubakar-Waziri H, Zhang J, Steveling E, Watchman S, Kouser L, Eifan A, Switzer A, Varricchi G, Marone G, Couto-Francisco NC, Calderon M, Durham SR. Shamji MH, et al. J Allergy Clin Immunol. 2019 Mar;143(3):1067-1076. doi: 10.1016/j.jaci.2018.09.039. Epub 2018 Nov 14. J Allergy Clin Immunol. 2019. PMID: 30445057 Free article.
Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis: The GRASS Randomized Clinical Trial.
Scadding GW, Calderon MA, Shamji MH, Eifan AO, Penagos M, Dumitru F, Sever ML, Bahnson HT, Lawson K, Harris KM, Plough AG, Panza JL, Qin T, Lim N, Tchao NK, Togias A, Durham SR; Immune Tolerance Network GRASS Study Team. Scadding GW, et al. JAMA. 2017 Feb 14;317(6):615-625. doi: 10.1001/jama.2016.21040. JAMA. 2017. PMID: 28196255 Free PMC article. Clinical Trial.
Protocol for a randomised, double-blind, placebo-controlled study of grass allergen immunotherapy tablet for seasonal allergic rhinitis: time course of nasal, cutaneous and immunological outcomes.
Steveling EH, Lao-Araya M, Koulias C, Scadding G, Eifan A, James LK, Dumitru A, Penagos M, Calderón M, Andersen PS, Shamji M, Durham SR. Steveling EH, et al. Clin Transl Allergy. 2015 Dec 17;5:43. doi: 10.1186/s13601-015-0087-2. eCollection 2015. Clin Transl Allergy. 2015. PMID: 26682038 Free PMC article.
Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy.
Vickery BP, Scurlock AM, Kulis M, Steele PH, Kamilaris J, Berglund JP, Burk C, Hiegel A, Carlisle S, Christie L, Perry TT, Pesek RD, Sheikh S, Virkud Y, Smith PB, Shamji MH, Durham SR, Jones SM, Burks AW. Vickery BP, et al. J Allergy Clin Immunol. 2014 Feb;133(2):468-75. doi: 10.1016/j.jaci.2013.11.007. Epub 2013 Dec 19. J Allergy Clin Immunol. 2014. PMID: 24361082 Free PMC article. Clinical Trial.
28 results